Cartier Resources Inc. (″Cartier ″ or the ″Company ″) (TSXV: ECR; FSE: 6CA) is pleased to announce the results of the Updated ...
The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results